Literature DB >> 27481006

Hepatocellular Carcinoma: The Current Role of Surgical Intervention.

Steve D Colquhoun1.   

Abstract

As the incidence of hepatocellular carcinoma (HCC) continues to rise, so does our understanding of this disease and the number of available treatment options and strategies. Although surgical intervention often continues to play a central role, it must be placed in the proper context of what has rapidly become a multimodality, multidisciplinary disease. Understanding the nuances of managing HCC and its associations and treatment options are essential for making appropriate surgical decisions.

Entities:  

Mesh:

Year:  2016        PMID: 27481006     DOI: 10.1615/CritRevOncog.2016016116

Source DB:  PubMed          Journal:  Crit Rev Oncog        ISSN: 0893-9675


  4 in total

1.  Exploration of Sorafenib Influences on Gene Expression of Hepatocellular Carcinoma.

Authors:  Huancheng Wang; Jia Liu
Journal:  Front Genet       Date:  2020-10-08       Impact factor: 4.599

2.  Circular RNA CircITCH (has-circ-0001141) suppresses hepatocellular carcinoma (HCC) progression by sponging miR-184.

Authors:  Xuan Guo; Ziying Wang; Xue Deng; Yantong Lu; Xuhui Huang; Juze Lin; Xiaohe Lan; Qiao Su; Changjun Wang
Journal:  Cell Cycle       Date:  2022-04-09       Impact factor: 5.173

3.  Differences Between Sorafenib and Lenvatinib Treatment from Genetic and Clinical Perspectives for Patients with Hepatocellular Carcinoma.

Authors:  Lei Wang; Lei Wang; Bo Xiao; Mingxuan Cui; Bo Zhang
Journal:  Med Sci Monit       Date:  2022-04-27

4.  Development and validation of LRP1B mutation-associated prognostic model for hepatocellular carcinoma.

Authors:  Jian Xu; Xiaomin Shen; Bo Zhang; Rui Su; Mingxuan Cui; Lihua Yan; Yu Cao
Journal:  Biosci Rep       Date:  2021-09-30       Impact factor: 3.840

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.